Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer, Baxter, RPR, Alpha Therapeutic offer $100,000 per claimant to HIV-infected hemophiliac plaintiffs.

Executive Summary

BAYER, BAXTER, RPR, ALPHA THERAPEUTIC OFFER $100,000 PER HEMOPHILIA CLAIMANT to a class of approximately 6,000 plaintiffs who allege that the companies negligently sold them blood-clotting products, Factor VIII and/or Factor IX, derived from HIV-tainted human blood plasma. The settlement offer is subject to a $640 mil. cap, including administrative costs and attorneys' fees. The class action dates to 1993.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028243

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel